{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T15:59:18Z","timestamp":1791993558344,"version":"4.4.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2006,9,10]],"date-time":"2006-09-10T00:00:00Z","timestamp":1157846400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2006,9,10]],"date-time":"2006-09-10T00:00:00Z","timestamp":1157846400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Cell Biol"],"published-print":{"date-parts":[[2006,10,1]]},"DOI":"10.1038\/ncb1471","type":"journal-article","created":{"date-parts":[[2006,9,10]],"date-time":"2006-09-10T13:23:50Z","timestamp":1157894630000},"page":"1053-1063","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":334,"title":["Anti-oncogenic role of the endoplasmic reticulum differentially activated by mutations in the MAPK pathway"],"prefix":"10.1038","volume":"8","author":[{"given":"Christophe","family":"Denoyelle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Abou-Rjaily","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir","family":"Bezrookove","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monique","family":"Verhaegen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy M.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas R.","family":"Fullen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny N.","family":"Pointer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen B.","family":"Gruber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lyndon D.","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikhail A.","family":"Nikiforov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randal J.","family":"Kaufman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boris C.","family":"Bastian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria S.","family":"Soengas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2006,9,10]]},"reference":[{"key":"BFncb1471_CR1","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3322\/canjclin.55.1.10","volume":"55","author":"A Jemal","year":"2005","unstructured":"Jemal, A. et al. Cancer statistics, 2005. CA Cancer J. Clin. 55, 10\u201330 (2005).","journal-title":"CA Cancer J. Clin."},{"key":"BFncb1471_CR2","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1038\/nature00766","volume":"417","author":"H Davies","year":"2002","unstructured":"Davies, H. et al. Mutations of the BRAF gene in human cancer. Nature 417, 949\u2013954 (2002).","journal-title":"Nature"},{"key":"BFncb1471_CR3","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/ng1054","volume":"33","author":"PM Pollock","year":"2003","unstructured":"Pollock, P. M. et al. High frequency of BRAF mutations in nevi. Nature Genet. 33, 19\u201320 (2003).","journal-title":"Nature Genet."},{"key":"BFncb1471_CR4","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1038\/nature03890","volume":"436","author":"C Michaloglou","year":"2005","unstructured":"Michaloglou, C. et al. BRAFE600-associated senescence-like cell cycle arrest of human naevi. Nature 436, 720\u2013724 (2005).","journal-title":"Nature"},{"key":"BFncb1471_CR5","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1080\/00313020412331283888","volume":"36","author":"I Strungs","year":"2004","unstructured":"Strungs, I. Common and uncommon variants of melanocytic naevi. Pathology 36, 396\u2013403 (2004).","journal-title":"Pathology"},{"key":"BFncb1471_CR6","first-page":"610","volume":"36","author":"T Papp","year":"1999","unstructured":"Papp, T. et al. Mutational analysis of the N-ras, p53, p16INK4a, CDK4, and MC1R genes in human congenital melanocytic naevi. J. Med. Genet. 36, 610\u2013614 (1999).","journal-title":"J. Med. Genet."},{"key":"BFncb1471_CR7","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1016\/S0002-9440(10)64609-3","volume":"157","author":"BC Bastian","year":"2000","unstructured":"Bastian, B. C., LeBoit, P. E. & Pinkel, D. Mutations and copy number increase of HRAS in Spitz nevi with distinctive histopathological features. Am. J. Pathol. 157, 967\u2013972 (2000).","journal-title":"Am. J. Pathol."},{"key":"BFncb1471_CR8","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/S0046-8177(99)90193-4","volume":"30","author":"RL Barnhill","year":"1999","unstructured":"Barnhill, R. L. et al. Atypical Spitz nevi\/tumors: lack of consensus for diagnosis, discrimination from melanoma, and prediction of outcome. Hum. Pathol. 30, 513\u2013520 (1999).","journal-title":"Hum. Pathol."},{"key":"BFncb1471_CR9","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1016\/S0002-9440(10)63736-4","volume":"164","author":"JL Maldonado","year":"2004","unstructured":"Maldonado, J. L., Timmerman, L., Fridlyand, J. & Bastian, B. C. Mechanisms of cell-cycle arrest in Spitz nevi with constitutive activation of the MAP-kinase pathway. Am. J. Pathol. 164, 1783\u20131787 (2004).","journal-title":"Am. J. Pathol."},{"key":"BFncb1471_CR10","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1038\/nrc1884","volume":"6","author":"M Collado","year":"2006","unstructured":"Collado, M. & Serrano, M. The power and the promise of oncogene-induced senescence markers. Nature Rev. Cancer 6, 472\u2013476 (2006).","journal-title":"Nature Rev. Cancer"},{"key":"BFncb1471_CR11","doi-asserted-by":"publisher","first-page":"2919","DOI":"10.1038\/sj.onc.1207518","volume":"23","author":"JW Shay","year":"2004","unstructured":"Shay, J. W. & Roninson, I. B. Hallmarks of senescence in carcinogenesis and cancer therapy. Oncogene 23, 2919\u20132933 (2004).","journal-title":"Oncogene"},{"key":"BFncb1471_CR12","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.cell.2005.02.003","volume":"120","author":"J Campisi","year":"2005","unstructured":"Campisi, J. Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors. Cell 120, 513\u2013522 (2005).","journal-title":"Cell"},{"key":"BFncb1471_CR13","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/sj.onc.1206886","volume":"23","author":"FA Mallette","year":"2004","unstructured":"Mallette, F. A., Goumard, S., Gaumont-Leclerc, M. F., Moiseeva, O. & Ferbeyre, G. Human fibroblasts require the Rb family of tumor suppressors, but not p53, for PML-induced senescence. Oncogene 23, 91\u201399 (2004).","journal-title":"Oncogene"},{"key":"BFncb1471_CR14","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.ceb.2005.06.010","volume":"17","author":"CM Federovitch","year":"2005","unstructured":"Federovitch, C. M., Ron, D. & Hampton, R. Y. The dynamic ER: experimental approaches and current questions. Curr. Opin. Cell Biol. 17, 409\u2013414 (2005).","journal-title":"Curr. Opin. Cell Biol."},{"key":"BFncb1471_CR15","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1146\/annurev.biochem.73.011303.074134","volume":"74","author":"M Schroder","year":"2005","unstructured":"Schroder, M. & Kaufman, R. J. The mammalian unfolded protein response. Annu. Rev. Biochem. 74, 739\u2013789 (2005).","journal-title":"Annu. Rev. Biochem."},{"key":"BFncb1471_CR16","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/S0968-0004(01)01908-9","volume":"26","author":"AS Lee","year":"2001","unstructured":"Lee, A. S. The glucose-regulated proteins: stress induction and clinical applications. Trends Biochem. Sci. 26, 504\u2013510 (2001).","journal-title":"Trends Biochem. Sci."},{"key":"BFncb1471_CR17","doi-asserted-by":"publisher","first-page":"2192","DOI":"10.1128\/MCB.21.6.2192-2202.2001","volume":"21","author":"I Lassot","year":"2001","unstructured":"Lassot, I. et al. ATF4 degradation relies on a phosphorylation-dependent interaction with the SCF(\u03b2TrCP) ubiquitin ligase. Mol. Cell. Biol. 21, 2192\u20132202 (2001).","journal-title":"Mol. Cell. Biol."},{"key":"BFncb1471_CR18","doi-asserted-by":"publisher","first-page":"4679","DOI":"10.1073\/pnas.90.10.4679","volume":"90","author":"M Vallejo","year":"1993","unstructured":"Vallejo, M., Ron, D., Miller, C. P. & Habener, J. F. C\/ATF, a member of the activating transcription factor family of DNA-binding proteins, dimerizes with CAAT\/enhancer-binding proteins and directs their binding to cAMP response elements. Proc. Natl Acad. Sci. USA 90, 4679\u20134683 (1993).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFncb1471_CR19","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1016\/S1097-2765(00)00108-8","volume":"6","author":"HP Harding","year":"2000","unstructured":"Harding, H. P. et al. Regulated translation initiation controls stress-induced gene expression in mammalian cells. Mol. Cell 6, 1099\u20131108 (2000).","journal-title":"Mol. Cell"},{"key":"BFncb1471_CR20","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1083\/jcb.200408117","volume":"167","author":"D Ron","year":"2004","unstructured":"Ron, D. & Hampton, R. Y. Membrane biogenesis and the unfolded protein response. J. Cell Biol. 167, 23\u201325 (2004).","journal-title":"J. Cell Biol."},{"key":"BFncb1471_CR21","doi-asserted-by":"publisher","first-page":"7690","DOI":"10.1073\/pnas.93.15.7690","volume":"93","author":"C Jamora","year":"1996","unstructured":"Jamora, C., Dennert, G. & Lee, A. S. Inhibition of tumor progression by suppression of stress protein GRP78\/BiP induction in fibrosarcoma B\/C10ME. Proc. Natl Acad. Sci. USA 93, 7690\u20137694 (1996).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFncb1471_CR22","doi-asserted-by":"publisher","first-page":"5943","DOI":"10.1158\/0008-5472.CAN-04-1606","volume":"64","author":"L Romero-Ramirez","year":"2004","unstructured":"Romero-Ramirez, L. et al. XBP1 is essential for survival under hypoxic conditions and is required for tumor growth. Cancer Res. 64, 5943\u20135947 (2004).","journal-title":"Cancer Res."},{"key":"BFncb1471_CR23","doi-asserted-by":"publisher","first-page":"2656","DOI":"10.1172\/JCI26373","volume":"115","author":"C Xu","year":"2005","unstructured":"Xu, C., Bailly-Maitre, B. & Reed, J. C. Endoplasmic reticulum stress: cell life and death decisions. J. Clin. Invest. 115, 2656\u20132664 (2005).","journal-title":"J. Clin. Invest."},{"key":"BFncb1471_CR24","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1038\/nrc1097","volume":"3","author":"M Malumbres","year":"2003","unstructured":"Malumbres, M. & Barbacid, M. RAS oncogenes: the first 30 years. Nature Rev. Cancer 3, 459\u2013465 (2003).","journal-title":"Nature Rev. Cancer"},{"key":"BFncb1471_CR25","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1042\/BST0330657","volume":"33","author":"MR Philips","year":"2005","unstructured":"Philips, M. R. Compartmentalized signalling of Ras. Biochem. Soc. Trans. 33, 657\u2013661 (2005).","journal-title":"Biochem. Soc. Trans."},{"key":"BFncb1471_CR26","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1128\/MCB.26.1.100-116.2006","volume":"26","author":"D Matallanas","year":"2006","unstructured":"Matallanas, D. et al. Distinct utilization of effectors and biological outcomes resulting from site-specific Ras activation: Ras functions in lipid rafts and Golgi complex are dispensable for proliferation and transformation. Mol. Cell. Biol. 26, 100\u2013116 (2006).","journal-title":"Mol. Cell. Biol."},{"key":"BFncb1471_CR27","doi-asserted-by":"publisher","first-page":"4005","DOI":"10.1158\/0008-5472.CAN-04-2970","volume":"65","author":"J Ackermann","year":"2005","unstructured":"Ackermann, J. et al. Metastasizing melanoma formation caused by expression of activated N-RasQ61K on an INK4a-deficient background. Cancer Res. 65, 4005\u20134011 (2005).","journal-title":"Cancer Res."},{"key":"BFncb1471_CR28","doi-asserted-by":"publisher","first-page":"37398","DOI":"10.1074\/jbc.M405730200","volume":"279","author":"W Li","year":"2004","unstructured":"Li, W., Zhu, T. & Guan, K. L. Transformation potential of Ras isoforms correlates with activation of phosphatidylinositol 3-kinase but not ERK. J. Biol. Chem. 279, 37398\u201337406 (2004).","journal-title":"J. Biol. Chem."},{"key":"BFncb1471_CR29","doi-asserted-by":"publisher","first-page":"3008","DOI":"10.1101\/gad.12.19.3008","volume":"12","author":"AW Lin","year":"1998","unstructured":"Lin, A. W. et al. Premature senescence involving p53 and p16 is activated in response to constitutive MEK\/MAPK mitogenic signaling. Genes Dev. 12, 3008\u20133019 (1998).","journal-title":"Genes Dev."},{"key":"BFncb1471_CR30","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/S0092-8674(03)00401-X","volume":"113","author":"M Narita","year":"2003","unstructured":"Narita, M. et al. Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence. Cell 113, 703\u2013716 (2003).","journal-title":"Cell"},{"key":"BFncb1471_CR31","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.yadr.2005.04.002","volume":"21","author":"J Bauer","year":"2005","unstructured":"Bauer, J. & Bastian, B. Genomic analysis of melanocytic neoplasia. Adv. Dermatol. 21, 81\u201399 (2005).","journal-title":"Adv. Dermatol."},{"key":"BFncb1471_CR32","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1038\/nm0905-920","volume":"11","author":"M Narita","year":"2005","unstructured":"Narita, M. & Lowe, S. W. Senescence comes of age. Nature Med. 11, 920\u2013922 (2005).","journal-title":"Nature Med."},{"key":"BFncb1471_CR33","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1038\/436636a","volume":"436","author":"NE Sharpless","year":"2005","unstructured":"Sharpless, N. E. & DePinho, R. A. Cancer: crime and punishment. Nature 436, 636\u2013637 (2005).","journal-title":"Nature"},{"key":"BFncb1471_CR34","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1038\/nature03841","volume":"436","author":"M Braig","year":"2005","unstructured":"Braig, M. et al. Oncogene-induced senescence as an initial barrier in lymphoma development. Nature 436, 660\u2013665 (2005).","journal-title":"Nature"},{"key":"BFncb1471_CR35","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1038\/nature03918","volume":"436","author":"Z Chen","year":"2005","unstructured":"Chen, Z. et al. Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis. Nature 436, 725\u2013730 (2005).","journal-title":"Nature"},{"key":"BFncb1471_CR36","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.4161\/cc.4.12.2260","volume":"4","author":"M Collado","year":"2005","unstructured":"Collado, M. & Serrano, M. The senescent side of tumor suppression. Cell Cycle 4, 1722\u20131724 (2005).","journal-title":"Cell Cycle"},{"key":"BFncb1471_CR37","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/S1535-6108(03)00191-0","volume":"4","author":"C Guerra","year":"2003","unstructured":"Guerra, C. et al. Tumor induction by an endogenous K-ras oncogene is highly dependent on cellular context. Cancer Cell 4, 111\u2013120 (2003).","journal-title":"Cancer Cell"},{"key":"BFncb1471_CR38","doi-asserted-by":"publisher","first-page":"2842","DOI":"10.1128\/MCB.24.7.2842-2852.2004","volume":"24","author":"JA Benanti","year":"2004","unstructured":"Benanti, J. A. & Galloway, D. A. Normal human fibroblasts are resistant to RAS-induced senescence. Mol. Cell. Biol. 24, 2842\u20132852 (2004).","journal-title":"Mol. Cell. Biol."},{"key":"BFncb1471_CR39","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/nature03098","volume":"432","author":"SW Lowe","year":"2004","unstructured":"Lowe, S. W., Cepero, E. & Evan, G. Intrinsic tumour suppression. Nature 432, 307\u2013315 (2004).","journal-title":"Nature"},{"key":"BFncb1471_CR40","first-page":"1876","volume":"62","author":"RH te Poele","year":"2002","unstructured":"te Poele, R. H., Okorokov, A. L., Jardine, L., Cummings, J. & Joel, S. P. DNA damage is able to induce senescence in tumor cells in vitro and in vivo. Cancer Res. 62, 1876\u20131883 (2002).","journal-title":"Cancer Res."},{"key":"BFncb1471_CR41","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1038\/nrc1505","volume":"4","author":"Y Ma","year":"2004","unstructured":"Ma, Y. & Hendershot, L. M. The role of the unfolded protein response in tumour development: friend or foe? Nature Rev. Cancer 4, 966\u2013977 (2004).","journal-title":"Nature Rev. Cancer"},{"key":"BFncb1471_CR42","doi-asserted-by":"publisher","first-page":"45","DOI":"10.2174\/156652406775574523","volume":"6","author":"J Li","year":"2006","unstructured":"Li, J. & Lee, A. S. Stress induction of GRP78\/BiP and its role in cancer. Curr. Mol. Med. 6, 45\u201354 (2006).","journal-title":"Curr. Mol. Med."},{"key":"BFncb1471_CR43","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1083\/jcb.200406136","volume":"167","author":"R Sriburi","year":"2004","unstructured":"Sriburi, R., Jackowski, S., Mori, K. & Brewer, J. W. XBP1: a link between the unfolded protein response, lipid biosynthesis, and biogenesis of the endoplasmic reticulum. J. Cell Biol. 167, 35\u201341 (2004).","journal-title":"J. Cell Biol."},{"key":"BFncb1471_CR44","doi-asserted-by":"publisher","first-page":"18691","DOI":"10.1074\/jbc.M602030200","volume":"281","author":"SH Back","year":"2006","unstructured":"Back, S. H., Lee, K., Vink, E. & Kaufman, R. J. Cytoplasmic IRE1\u03b1-mediated XBP1 mRNA splicing in the absence of nuclear processing and endoplasmic reticulum stress. J. Biol. Chem. 281, 18691\u201318706 (2006).","journal-title":"J. Biol. Chem."},{"key":"BFncb1471_CR45","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/S1097-2765(03)00105-9","volume":"11","author":"HP Harding","year":"2003","unstructured":"Harding, H. P. et al. An integrated stress response regulates amino acid metabolism and resistance to oxidative stress. Mol. Cell 11, 619\u2013633 (2003).","journal-title":"Mol. Cell"},{"key":"BFncb1471_CR46","doi-asserted-by":"publisher","first-page":"7469","DOI":"10.1128\/MCB.24.17.7469-7482.2004","volume":"24","author":"JD Blais","year":"2004","unstructured":"Blais, J. D. et al. Activating transcription factor 4 is translationally regulated by hypoxic stress. Mol. Cell. Biol. 24, 7469\u20137482 (2004).","journal-title":"Mol. Cell. Biol."},{"key":"BFncb1471_CR47","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1200\/JCO.2005.07.168","volume":"23","author":"DL Dai","year":"2005","unstructured":"Dai, D. L., Martinka, M. & Li, G. Prognostic significance of activated Akt expression in melanoma: a clinicopathologic study of 292 cases. J. Clin. Oncol. 23, 1473\u20131482 (2005).","journal-title":"J. Clin. Oncol."},{"key":"BFncb1471_CR48","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1038\/sj.emboj.7600045","volume":"23","author":"H Miyauchi","year":"2004","unstructured":"Miyauchi, H. et al. Akt negatively regulates the in vitro lifespan of human endothelial cells via a p53\/p21-dependent pathway. EMBO J. 23, 212\u2013220 (2004).","journal-title":"EMBO J."},{"key":"BFncb1471_CR49","doi-asserted-by":"publisher","first-page":"5493","DOI":"10.1091\/mbc.e05-03-0268","volume":"16","author":"RB Hamanaka","year":"2005","unstructured":"Hamanaka, R. B., Bennett, B. S., Cullinan, S. B. & Diehl, J. A. PERK and GCN2 contribute to eIF2\u03b1 phosphorylation and cell cycle arrest after activation of the unfolded protein response pathway. Mol. Biol. Cell 16, 5493\u20135501 (2005).","journal-title":"Mol. Biol. Cell"},{"key":"BFncb1471_CR50","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1158\/0008-5472.CAN-05-3092","volume":"66","author":"AC Ranganathan","year":"2006","unstructured":"Ranganathan, A. C., Zhang, L., Adam, A. P. & Aguirre-Ghiso, J. A. Functional coupling of p38-induced up-regulation of BiP and activation of RNA-dependent protein kinase-like endoplasmic reticulum kinase to drug resistance of dormant carcinoma cells. Cancer Res. 66, 1702\u20131711 (2006).","journal-title":"Cancer Res."},{"key":"BFncb1471_CR51","doi-asserted-by":"crossref","first-page":"27013","DOI":"10.1016\/S0021-9258(19)61473-0","volume":"275","author":"Y Wang","year":"2000","unstructured":"Wang, Y. et al. Activation of ATF6 and an ATF6 DNA binding site by the endoplasmic reticulum stress response. J. Biol. Chem. 275, 27013\u201327020 (2000).","journal-title":"J. Biol. Chem."}],"updated-by":[{"DOI":"10.1038\/ncb1106-1309","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2006,11,1]],"date-time":"2006-11-01T00:00:00Z","timestamp":1162339200000}}],"container-title":["Nature Cell Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ncb1471.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ncb1471","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ncb1471.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T15:28:47Z","timestamp":1684423727000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ncb1471"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9,10]]},"references-count":51,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2006,10,1]]}},"alternative-id":["BFncb1471"],"URL":"https:\/\/doi.org\/10.1038\/ncb1471","relation":{},"ISSN":["1465-7392","1476-4679"],"issn-type":[{"value":"1465-7392","type":"print"},{"value":"1476-4679","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,9,10]]},"assertion":[{"value":"28 April 2006","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2006","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2006","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}